Related Experiment Video
Updated: Jul 7, 2026

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
Endothelial progenitor cell mediates transport of hepatitis B
Qi-fei Rong1, Jun Huang, En-ben Su
1Department of Cardiology, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China.
Insights
Endothelial progenitor cells (EPCs) can carry Hepatitis B virus (HBV) into heart tissues, suggesting a new pathway for HBV-associated myocarditis. This research clarifies how the virus spreads to extrahepatic sites.
Area of Science:
- Virology
- Cardiology
- Cell Biology
Background:
- Hepatitis B virus (HBV) is linked to extrahepatic disorders, but its transmission to organs like the heart and the cause of HBV-associated myocarditis are unclear.
- Understanding HBV's extrahepatic spread is crucial for managing associated conditions.
Purpose of the Study:
- To investigate the mechanism of HBV trans-infection into myocardial tissue.
- To determine if endothelial progenitor cells (EPCs) play a role in HBV-associated myocarditis.
Main Methods:
- Infection of human cord blood EPCs and human umbilical vein endothelial cells (HUVECs) with HBV in vitro.
- Transfusion of HBV-infected EPCs into a myocardial infarction mouse model.
- Detection of HBV antigens, particles, and DNA using immunohistochemistry, flow cytometry, and PCR.
- Transmission electron microscopy to visualize HBV particles within EPCs.
- In vivo analysis of EPC and HBV incorporation into injured myocardial tissues.
Main Results:
- Human cord blood EPCs, unlike HUVECs, were effectively infected by HBV in vitro.
- HBV antigens and particles were detected in EPCs for up to 11 days and 3 weeks, respectively.
- HBV DNA, but not cccDNA, persisted in EPCs for at least 3 weeks post-infection.
- Transplanted HBV-treated EPCs were found in the injured capillaries of the ischemic border zone in rats.
Conclusions:
- EPCs act as carriers, facilitating HBV trans-infection into injured myocardial tissue.
- This study proposes a novel mechanism for the development of HBV-associated myocarditis.
Background:
Hepatitis B virus (HBV) replication has been reported to be involved in many extrahepatic viral disorders; however, the mechanism by which HBV is transinfected into extrahepatic tissues such as myocardium and causes HBV associated myocarditis remains largely unknown.
Methods:
In this study, endothelial progenitor cells (EPCs) were infected by HBV and then transfused into ischemic model of mice. HBV surface and core antigen as well as mutation of HBV particles were detected by immunohistochemistry, fluorescent activated cell sorter and transmission electron microscopy in vitro and in vivo.
Results:
Human cord blood EPCs, but not human umbilical vein endothelial cells (HUVECs) could be effectively infected by taking up HBV in vitro. HBV envelope surface and core antigen expressions were first detectable in EPCs at day 3 after virus challenge, sustained for up to 11 days, and decreased thereafter. Similarly, the virus particles were the most abundant in EPCs in the first week observed by a transmission electron microscope, and declined in 3 weeks after HBV infection. HBV DNA but not HBV cccDNA in EPCs were detectable even 3 weeks after virus challenge, as shown by PCR analysis. Furthermore, intravenous transplantation of HBV-treated EPCs into myocardial infarction Sprague & Dawley rats model resulted in incorporation of both EPCs and HBV into injured endothelial tissues of capillaries in the ischemic border zone.
Conclusions:
These results strongly support that EPCs serve as virus carrier mediating HBV trans-infection into the injured myocardial tissues. The findings might suggest a novel mechanism for HBV-associated myocarditis.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Multipotency of Hematopoietic Stem Cells
Hepatic Drug Clearance: Role of Transporters
Hematopoiesis

